S1P Therapeutics Inc. — Form D
S1P Therapeutics Inc. of BLACKSBURG, VA, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-09. The offering totals $3.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-06-09
- Form: D
- Accession: 0001980623-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.0M
- Remaining: $983K
- Investors: 1
- Date of first sale: 2023-05-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-483795
Issuer
- Name: S1P Therapeutics Inc.
- CIK: 0001980623
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 501 WILDFLOWER LANE, BLACKSBURG, VA, 24060
- Phone: 703-679-2626
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Kevin Lynch | Director | Blacksburg, VA |
| Webster Santos | Director | Blacksburg, VA |
| Ronald Sayco | Director | Blacksburg, VA |
| Kevin Lynch | Executive Officer | Blacksburg, VA |
| Webster Santos | Executive Officer | Blacksburg, VA |
| Ronald Sayco | Executive Officer | Blacksburg, VA |
More